Allosteric SHP2 inhibitors in cancer: Targeting the intersection of RAS, resistance, and the immune microenvironment
Author:
Funder
Novartis
Revolution Medicines and Strategia
NIH
NCI
Pew and Stewart Foundations
German Cancer Aid
Publisher
Elsevier BV
Subject
Biochemistry,Analytical Chemistry
Reference100 articles.
1. The ‘Shp’ing news: SH2 domain-containing tyrosine phosphatases in cell signaling;Neel;Trends Biochem Sci,2003
2. Revealing mechanisms for SH2 domain mediated regulation of the protein tyrosine phosphatase SHP-2;Barford;Structure,1998
3. Structural and functional consequences of three cancer-associated mutations of the oncogenic phosphatase SHP2;LaRochelle;Biochemistry,2016
4. Structural reorganization of SHP2 by oncogenic mutations and implications for oncoprotein resistance to allosteric inhibition;LaRochelle;Nat Commun,2018
5. Molecular mechanism of SHP2 activation by PD-1 stimulation;Marasco;Sci Adv,2020
Cited by 94 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. SHANK3 depletion leads to ERK signalling overdose and cell death in KRAS-mutant cancers;Nature Communications;2024-09-12
2. Advances in SHP2 tunnel allosteric inhibitors and bifunctional molecules;European Journal of Medicinal Chemistry;2024-09
3. Discovery of JAB-3312, a Potent SHP2 Allosteric Inhibitor for Cancer Treatment;Journal of Medicinal Chemistry;2024-08-07
4. Design, Synthesis and Antitumor Activity of a Novel Class of SHP2 Allosteric Inhibitors with a Furanyl Amide-Based Scaffold;Journal of Medicinal Chemistry;2024-07-27
5. Enzyme Is the Name—Adapter Is the Game;Cells;2024-07-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3